Hemoglobin A@c levels were significantly and durably reduced from baseline ( least-squares mean , -@ % ; @ % CI , -@ % to -@ % ; vs -@ % for exenatide once weekly at week @ ) , and @ ( @ % ) of @ patients achieved hemoglobin A@c levels of less than @ % .